Ocugen Inc

NASDAQ:OCGN   3:59:59 PM EDT
8.33
-0.13 (-1.54%)
4:42:27 PM EDT: $8.38 +0.05 (+0.60%)
Products, Strategic Combinations, Regulatory

Ocugen Inc - Entered Into A Development And Commercial Supply Agreement With Bharat Biotech International

Published: 10/04/2021 20:26 GMT
Ocugen Inc (OCGN) - Ocugen Inc - Entered Into a Development and Commercial Supply Agreement With Bharat Biotech International.
Ocugen Inc - Bharat Biotech Will Exclusively Manufacture and Supply the Company With Its Requirements of Covaxin Clinical Trial Materials.
Ocugen - Bharat Biotech Will Manufacture and Supply Covaxin Drug Product Components & Finished Drug Product As Necessary for Commercial Supply of Covaxin.
Ocugen Inc - Entered Into a First Amendment to the Co-development and Commercialization Agreement With Cansino Biologics, Inc.ocugen Inc - Ocu410 Will Be Added to the Company’s Existing Collaboration With Cansino.
Ocugen Inc - Cansino Will Be Responsible for the Chemistry, Manufacturing, and Controls Development and Manufacture of Clinical Supplies of Ocu410.